Active 0 6 0 6 B-clinical_variable
grade 7 12 7 12 I-clinical_variable
≥ 13 14 13 14 O
2 15 16 15 16 B-lower_bound
bleeding 17 25 17 25 O
at 26 28 26 28 O
the 29 32 29 32 O
time 33 37 33 37 O
of 38 40 38 40 O
randomization 41 54 41 54 O
, 54 55 54 55 O
including 56 65 56 65 O
hematuria 66 75 66 75 B-chronic_disease

Acute 0 5 76 81 O
or 6 8 82 84 O
chronic 9 16 85 92 B-chronic_disease
thrombocytopenia 17 33 93 109 I-chronic_disease
in 34 36 110 112 O
patients 37 45 113 121 O
with 46 50 122 126 O
acute 51 56 127 132 B-cancer
leukemia 57 65 133 141 I-cancer
( 66 67 142 143 O
myeloblastic 67 79 143 155 B-cancer
or 80 82 156 158 O
lymphoblastic 83 96 159 172 B-cancer
) 96 97 172 173 O
receiving 98 107 174 183 O
induction 108 117 184 193 B-treatment
or 118 120 194 196 I-treatment
re 121 123 197 199 I-treatment
- 123 124 199 200 I-treatment
induction 124 133 200 209 I-treatment
chemotherapy 134 146 210 222 I-treatment
that 147 151 223 227 O
is 152 154 228 230 O
expected 155 163 231 239 O
to 164 166 240 242 O
induce 167 173 243 249 O
marrow 174 180 250 256 O
aplasia 181 188 257 264 O
for 189 192 265 268 O
at 193 195 269 271 O
least 196 201 272 277 O
2 202 203 278 279 B-lower_bound
weeks 204 209 280 285 I-lower_bound

Acute 0 5 286 291 B-cancer
promyelocytic 6 19 292 305 I-cancer
leukemia 20 28 306 314 I-cancer

Acute 0 5 315 320 B-chronic_disease
thrombocytopenia 6 22 321 337 I-chronic_disease
in 23 25 338 340 O
patients 26 34 341 349 O
with 35 39 350 354 O
hematological 40 53 355 368 B-cancer
malignancies 54 66 369 381 I-cancer
who 67 70 382 385 O
are 71 74 386 389 O
in 75 77 390 392 O
remission 78 87 393 402 O
and 88 91 403 406 O
are 92 95 407 410 O
receiving 96 105 411 420 O
myelosuppressive 106 122 421 437 B-treatment
consolidation 123 136 438 451 I-treatment
chemotherapy 137 149 452 464 I-treatment
that 150 154 465 469 O
is 155 157 470 472 O
expected 158 166 473 481 O
to 167 169 482 484 O
induce 170 176 485 491 O
marrow 177 183 492 498 B-chronic_disease
aplasia 184 191 499 506 I-chronic_disease
for 192 195 507 510 O
at 196 198 511 513 O
least 199 204 514 519 O
2 205 206 520 521 B-lower_bound
weeks 207 212 522 527 I-lower_bound

Age 0 3 528 531 B-age
> 4 5 532 533 O
18 6 8 534 536 B-lower_bound
with 9 13 537 541 O
a 14 15 542 543 O
hematological 16 29 544 557 B-cancer
malignancy 30 40 558 568 I-cancer

Disseminated 0 12 569 581 B-chronic_disease
intravascular 13 26 582 595 I-chronic_disease
coagulation 27 38 596 607 I-chronic_disease

Expected 0 8 608 616 O
chronic 9 16 617 624 B-chronic_disease
thrombocytopenia 17 33 625 641 I-chronic_disease
in 34 36 642 644 O
patients 37 45 645 653 O
with 46 50 654 658 O
newly 51 56 659 664 O
diagnosed 57 66 665 674 O
marrow 67 73 675 681 B-chronic_disease
failure 74 81 682 689 I-chronic_disease
syndromes 82 91 690 699 I-chronic_disease
, 91 92 699 700 O
myelodysplastic 93 108 701 716 B-cancer
syndromes 109 118 717 726 I-cancer
, 118 119 726 727 O
aplastic 120 128 728 736 B-chronic_disease
anemia 129 135 737 743 I-chronic_disease
, 135 136 743 744 O
chronic 137 144 745 752 B-cancer
myelomonocytic 145 159 753 767 I-cancer
leukemia 160 168 768 776 I-cancer
or 169 171 777 779 O
myelofibrosis 172 185 780 793 B-cancer

Expected 0 8 794 802 O
chronic 9 16 803 810 B-chronic_disease
thrombocytopenia 17 33 811 827 I-chronic_disease
in 34 36 828 830 O
patients 37 45 831 839 O
with 46 50 840 844 O
relapsed 51 59 845 853 B-cancer
or 60 62 854 856 O
refractory 63 73 857 867 B-cancer
hematological 74 87 868 881 I-cancer
malignancies 88 100 882 894 I-cancer

Fibrinogen 0 10 895 905 B-clinical_variable
level 11 16 906 911 I-clinical_variable
< 17 18 912 913 O
150 19 22 914 917 B-upper_bound
mg 23 25 918 920 I-upper_bound
/ 25 26 920 921 I-upper_bound
dl 26 28 921 923 I-upper_bound

Grade 0 5 924 929 B-chronic_disease
2 6 7 930 931 I-chronic_disease
renal 8 13 932 937 I-chronic_disease
dysfunction 14 25 938 949 I-chronic_disease

Hematopoietic 0 13 950 963 B-treatment
stem 14 18 964 968 I-treatment
cell 19 23 969 973 I-treatment
transplant 24 34 974 984 I-treatment
recipient 35 44 985 994 O
within 45 51 995 1001 O
100 52 55 1002 1005 B-upper_bound
days 56 60 1006 1010 I-upper_bound
post 61 65 1011 1015 O
- 65 66 1015 1016 O
transplant 66 76 1016 1026 O

Hematopoietic 0 13 1027 1040 B-treatment
stem 14 18 1041 1045 I-treatment
cell 19 23 1046 1050 I-treatment
transplant 24 34 1051 1061 I-treatment
recipients 35 45 1062 1072 O
with 46 50 1073 1077 O
chronic 51 58 1078 1085 O
thrombocytopenia 59 75 1086 1102 B-chronic_disease
due 76 79 1103 1106 O
to 80 82 1107 1109 O
chronic 83 90 1110 1117 O
graft 91 96 1118 1123 O
- 96 97 1123 1124 O
versus 97 103 1124 1130 O
- 103 104 1130 1131 O
host 104 108 1131 1135 O
disease 109 116 1136 1143 O
( 117 118 1144 1145 O
GVHD 118 122 1145 1149 B-chronic_disease
) 122 123 1149 1150 O
or 124 126 1151 1153 O
other 127 132 1154 1159 O
causes 133 139 1160 1166 O

History 0 7 1167 1174 O
of 8 10 1175 1177 O
arterial 11 19 1178 1186 B-chronic_disease
or 20 22 1187 1189 O
venous 23 29 1190 1196 B-chronic_disease
thromboembolic 30 44 1197 1211 I-chronic_disease
disease 45 52 1212 1219 O
6 53 54 1220 1221 O
months 55 61 1222 1228 O
prior 62 67 1229 1234 O
to 68 70 1235 1237 O
screening 71 80 1238 1247 O

History 0 7 1248 1255 O
of 8 10 1256 1258 O
veno 11 15 1259 1263 B-chronic_disease
- 15 16 1263 1264 I-chronic_disease
occlusive 16 25 1264 1273 I-chronic_disease
disease 26 33 1274 1281 I-chronic_disease
of 34 36 1282 1284 I-chronic_disease
the 37 40 1285 1288 I-chronic_disease
liver 41 46 1289 1294 I-chronic_disease

Known 0 5 1295 1300 O
allergy 6 13 1301 1308 O
to 14 16 1309 1311 O
EACA 17 21 1312 1316 B-allergy_name

Myocardial 0 10 1317 1327 B-chronic_disease
infarction 11 21 1328 1338 I-chronic_disease
6 22 23 1339 1340 B-upper_bound
months 24 30 1341 1347 I-upper_bound
prior 31 36 1348 1353 I-upper_bound
to 37 39 1354 1356 O
screening 40 49 1357 1366 O

Patient 0 7 1367 1374 O
receiving 8 17 1375 1384 O
anticoagulation 18 33 1385 1400 B-treatment

Patient 0 7 1401 1408 O
receiving 8 17 1409 1418 O
antiplatelet 18 30 1419 1431 B-treatment
agents 31 37 1432 1438 I-treatment

Patient 0 7 1439 1446 O
requiring 8 17 1447 1456 O
platelet 18 26 1457 1465 B-clinical_variable
transfusion 27 38 1466 1477 I-clinical_variable
threshold 39 48 1478 1487 I-clinical_variable
of 49 51 1488 1490 O
> 52 53 1491 1492 O
20 54 56 1493 1495 B-lower_bound
x 57 58 1496 1497 I-lower_bound
10⁹/L 59 64 1498 1503 I-lower_bound

Patient 0 7 1504 1511 O
treated 8 15 1512 1519 O
with 16 20 1520 1524 O
antifibrinolytic 21 37 1525 1541 B-treatment
agents 38 44 1542 1548 I-treatment
( 45 46 1549 1550 O
including 46 55 1550 1559 O
EACA 56 60 1560 1564 B-treatment
) 60 61 1564 1565 O
within 62 68 1566 1572 O
14 69 71 1573 1575 B-upper_bound
days 72 76 1576 1580 I-upper_bound
prior 77 82 1581 1586 I-upper_bound
to 83 85 1587 1589 O
screening 86 95 1590 1599 O

Patients 0 8 1600 1608 O
with 9 13 1609 1613 O
known 14 19 1614 1619 O
lupus 20 25 1620 1625 B-chronic_disease
anticoagulant 26 39 1626 1639 I-chronic_disease
or 40 42 1640 1642 O
positive 43 51 1643 1651 B-chronic_disease
antiphospholipid 52 68 1652 1668 I-chronic_disease
antibody 69 77 1669 1677 I-chronic_disease

Pregnancy 0 9 1678 1687 B-pregnancy

Subject 0 7 1688 1695 O
with 8 12 1696 1700 O
known 13 18 1701 1706 O
congenital 19 29 1707 1717 O
bleeding 30 38 1718 1726 I-chronic_disease
disorders 39 48 1727 1736 I-chronic_disease
or 49 51 1737 1739 O
platelet 52 60 1740 1748 B-chronic_disease
dysfunction 61 72 1749 1760 I-chronic_disease

Subjects 0 8 1761 1769 O
receiving 9 18 1770 1779 O
procoagulant 19 31 1780 1792 O
agent 32 37 1793 1798 O
including 38 47 1799 1808 O
DDAVP 48 53 1809 1814 B-treatment
, 53 54 1814 1815 O
recombinant 55 66 1816 1827 B-treatment
factor 67 73 1828 1834 I-treatment
VII 74 77 1835 1838 I-treatment
or 78 80 1839 1841 O
prothrombin 81 92 1842 1853 B-treatment
complex 93 100 1854 1861 I-treatment
concentrate 101 112 1862 1873 I-treatment
within 113 119 1874 1880 O
24 120 122 1881 1883 B-upper_bound
hours 123 128 1884 1889 I-upper_bound
of 129 131 1890 1892 O
enrollment 132 142 1893 1903 O

Thrombocytopenia 0 16 1904 1920 B-cancer
with 17 21 1921 1925 O
untransfused 22 34 1926 1938 O
platelet 35 43 1939 1947 B-clinical_variable
counts 44 50 1948 1954 I-clinical_variable
< 51 52 1955 1956 O
20 53 55 1957 1959 B-upper_bound
x 56 57 1960 1961 I-upper_bound
10⁹/L 58 63 1962 1967 I-upper_bound
in 64 66 1968 1970 O
the 67 70 1971 1974 O
out 71 74 1975 1978 O
- 74 75 1978 1979 O
patient 75 82 1979 1986 O
or 83 85 1987 1989 O
in 86 88 1990 1992 O
the 89 92 1993 1996 O
in 93 95 1997 1999 O
- 95 96 1999 2000 O
patient 96 103 2000 2007 O
setting 104 111 2008 2015 O

Unstable 0 8 2016 2024 B-chronic_disease
angina 9 15 2025 2031 I-chronic_disease

creatinine 0 10 2032 2042 B-clinical_variable
> 11 12 2043 2044 O
2 13 14 2045 2046 B-lower_bound
- 14 15 2046 2047 O
3 15 16 2047 2048 B-upper_bound
times 17 22 2049 2054 I-upper_bound
the 23 26 2055 2058 I-upper_bound
upper 27 32 2059 2064 I-upper_bound
limit 33 38 2065 2070 I-upper_bound
of 39 41 2071 2073 I-upper_bound
normal 42 48 2074 2080 I-upper_bound

